Tag: pharmaceutical patents

Secondary Patents: How Pharmaceutical Brands Extend Market Exclusivity

Secondary Patents: How Pharmaceutical Brands Extend Market Exclusivity

Secondary patents let pharmaceutical companies extend market exclusivity by patenting minor changes to drugs - not the active ingredient, but how it's delivered, used, or made. These tactics delay generics and keep prices high.

RECENT POSTS

November 29, 2025
Switching to an Authorized Generic: Managing Patient Transitions

Learn how switching to an authorized generic can improve medication safety and reduce side effects compared to regular generics - and how to make sure you get the right version at the right price.

December 10, 2025
Generic vs Brand Name Drugs: What the Label Really Tells You and Why They Work the Same

Generic drugs save billions and work just as well as brand-name versions. Learn what the FDA requires for therapeutic equivalence, why labels look different, and when to watch for subtle changes.

October 27, 2025
Atazanavir and Workplace Rights: What You Need to Know

If you're taking atazanavir for HIV, you have legal rights at work. Learn what accommodations you can request, how to ask for them, and how to protect yourself from discrimination-all without revealing your diagnosis.

November 1, 2025
Compare Anafranil (Clomipramine) with Alternatives for OCD and Depression

Anafranil (clomipramine) is effective for OCD but has tough side effects. Discover how SSRIs like Zoloft and Prozac compare as safer, nearly as effective alternatives - and when Anafranil might still be the best choice.

September 7, 2024
Losartan and Its Impact on Lowering Eye Pressure in Glaucoma Patients

This article delves into how Losartan, a medication commonly used for hypertension, may have potential benefits in lowering eye pressure in glaucoma patients. By examining recent studies and scientific findings, we explore the mechanism behind Losartan’s effects on intraocular pressure and offer practical insights for those managing glaucoma.